Codexis Inc
Codexis Inc (CDXS) Option Chain
As of September 17, 2026, Codexis Inc is trading at $1.35, a +2.28% change from the previous close. The nearest expiration is Oct 16, 2026. Implied volatility is 327.2%. IV Rank is 84%.
Read more
Tracking the CDXS option chain helps you see every strike and expiry on Codexis Inc in one view, so you can quickly identify the contracts that fit your thesis and your risk. Codexis Inc's option chain lays out bids, asks, volume, open interest, and Greeks across calls and puts, giving you the full map of CDXS options activity at a glance. Use our scanner to monitor the CDXS option chain in real time and filter for the CDXS options trades that actually meet your criteria.
An option chain is the complete listing of all available option contracts on an underlying, organized by expiration date and strike price. For CDXS stock options, the chain shows side-by-side call and put data, making it easy to compare premiums, assess liquidity, and spot pricing dislocations. Reading the CDXS option chain effectively means looking beyond the last price — implied volatility by strike, volume-to-open-interest ratios, and bid-ask spreads all tell you where CDXS stock options are being actively traded and where they are not.
Codexis, Inc. discovers, develops, and sells enzymes and other proteins. It offers biocatalyst products and services; intermediate chemicals products that are used for further chemical processing; and Codex biocatalyst panels and kits that enable customers to perform chemistry screening. The company also provides biocatalyst screening and protein engineering services. In addition, it offers CodeEvolver protein engineering technology platform, which helps in developing and delivering biocatalysts that perform chemical transformations and enhance the efficiency and productivity of manufacturing processes.
The company's platform is also used to discover novel biotherapeutic drug candidates for targeted human diseases, as well as for molecular biology and in vitro diagnostic enzymes. It sells its products to pharmaceutical manufacturers through its direct sales and business development force in the United States and Europe. The company was incorporated in 2002 and is headquartered in Redwood City, California.
Credit spreads, long calls, iron condors, calendar trades — every strategy starts with the same raw material: a clean, complete option chain. Our scanner pulls Codexis Inc's full chain across every expiry, highlights the most liquid strikes, and lets you screen CDXS options by the metrics that matter, from IV skew to volume surges. Stop scrolling through endless rows of CDXS stock options — let the full option chain come to you, pre-filtered and ready to trade.
Stock Statistics
- IndustryBiotechnology
- SectorHealthcare
- IV percentile85.32% Elevated
- Market cap (M$)145
- 52 weeks high-55.70%
- 52 weeks low37.50%
- Analyst recommendationBuy
1.57 - Target price$6.33
368.89% above the current stock price - Dividend—
- Payout ratio—
- Earnings date2026-11-05
- P/E—
- Future P/E—
- EPS (ttm)-0.34
- EPS growth next 5 years53.58%
As of September 17, 2026
| CALLs | PUTs | ||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Prob. OTM % | Open Interest | Volume | Extrinsic Value | Intrinsic Value | Bid | Ask | Strike | Moneyness % | Bid | Ask | Intrinsic Value | Extrinsic Value | Volume | Open Interest | Prob. OTM % |
| 27.32 | 0 | 0 | 0.10 | 0.85 | 0.45 | 1.45 | 0.50 | -62.12 | — | 0.75 | 0.00 | 0.75 | 0 | 0 | 72.68 |
| 56.06 | 0 | 0 | 0.20 | 0.35 | 0.05 | 1.05 | 1.00 | -24.24 | — | 1.00 | 0.00 | 1.00 | 0 | 0 | 43.94 |
| 72.39 | 30 | 0 | 1.00 | 0.00 | — | 1.00 | 1.50 | +13.64 | — | 1.00 | 0.15 | 0.85 | 0 | 51 | 27.61 |
| 81.81 | 0 | 0 | 0.35 | 0.00 | — | 0.35 | 2.00 | +51.52 | 0.20 | 1.20 | 0.65 | 0.05 | 0 | 0 | 18.19 |
| 87.52 | 0 | 0 | 0.50 | 0.00 | — | 0.50 | 2.50 | +89.39 | 0.65 | 1.65 | 1.15 | 0.00 | 0 | 0 | 12.48 |
As of September 17, 2026
Scan the full option chain in one place
Browse the full CDXS option chain across every strike and expiration, filter by IV, volume, and open interest, and evaluate your trade without switching tools.
Start your 14-day free trial→